GB9315755D0 - Stabilized formulation - Google Patents

Stabilized formulation

Info

Publication number
GB9315755D0
GB9315755D0 GB939315755A GB9315755A GB9315755D0 GB 9315755 D0 GB9315755 D0 GB 9315755D0 GB 939315755 A GB939315755 A GB 939315755A GB 9315755 A GB9315755 A GB 9315755A GB 9315755 D0 GB9315755 D0 GB 9315755D0
Authority
GB
United Kingdom
Prior art keywords
stabilized formulation
stabilized
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939315755A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB939315755A priority Critical patent/GB9315755D0/en
Publication of GB9315755D0 publication Critical patent/GB9315755D0/en
Priority to IL11055194A priority patent/IL110511A0/en
Priority to PCT/GB1994/001643 priority patent/WO1995003805A1/en
Priority to AU72353/94A priority patent/AU7235394A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
GB939315755A 1993-07-30 1993-07-30 Stabilized formulation Pending GB9315755D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB939315755A GB9315755D0 (en) 1993-07-30 1993-07-30 Stabilized formulation
IL11055194A IL110511A0 (en) 1993-07-30 1994-07-29 Topical pharmaceutical formulation for treating viral infections
PCT/GB1994/001643 WO1995003805A1 (en) 1993-07-30 1994-07-29 Stabilized formulation
AU72353/94A AU7235394A (en) 1993-07-30 1994-07-29 Stabilized formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939315755A GB9315755D0 (en) 1993-07-30 1993-07-30 Stabilized formulation

Publications (1)

Publication Number Publication Date
GB9315755D0 true GB9315755D0 (en) 1993-09-15

Family

ID=10739668

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939315755A Pending GB9315755D0 (en) 1993-07-30 1993-07-30 Stabilized formulation

Country Status (4)

Country Link
AU (1) AU7235394A (en)
GB (1) GB9315755D0 (en)
IL (1) IL110511A0 (en)
WO (1) WO1995003805A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ1966A1 (en) 1995-02-06 2002-10-15 Astra Ab New pharmaceutical combination.
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
DZ1965A1 (en) * 1995-02-06 2002-07-17 Astra Ab New pharmaceutical composition.
DE19517147C2 (en) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Acyclovir preparation
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
JP4972062B2 (en) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ Antiviral preparation
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR830005852A (en) * 1980-07-18 1983-09-14 미첼 페터 잭슨 Preparation of topical treatments suitable for the treatment of viral infections on skin and mucous membranes
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor

Also Published As

Publication number Publication date
WO1995003805A1 (en) 1995-02-09
IL110511A0 (en) 1994-10-21
AU7235394A (en) 1995-02-28

Similar Documents

Publication Publication Date Title
AP9400704A0 (en) Novel formulation
GB9103824D0 (en) Formulation
GB9315755D0 (en) Stabilized formulation
GB9221883D0 (en) Novel formulation
GB9325869D0 (en) Formulation
GB9312960D0 (en) Formulation
GB9312938D0 (en) Formulation
GB9302189D0 (en) Formulation
GB9404989D0 (en) Lipomimetric formulation
GB9217322D0 (en) Formulation
GB9225583D0 (en) Formulation
ZA928061B (en) Lipomimetic formulation
GB9205183D0 (en) Formulation
GB9202110D0 (en) Formulation
GB9201915D0 (en) Formulation
GB9312354D0 (en) Novel formulation
GB9316326D0 (en) Novel formulation
GB9312355D0 (en) Novel formulation
ZA946797B (en) Stabilized tablet formulation
GB9323864D0 (en) Stabilized tablet formulation
GB9306144D0 (en) Formulations
GB9308622D0 (en) Formulations
GB9212757D0 (en) Novel formulation
GB9216361D0 (en) Novel formulation
GB9212711D0 (en) Novel formulation